Home > PB Ratio > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
PB (Price/Book ) Ratio

The Current P/B Ratio of STRIDES PHARMA SCIENCE is 2.97.

Share Price ₹684.3Dec 20,2024
Market Cap ₹6,309.2 Cr
Book Value₹2,122.5 CrMar2024 - Consolidated Results
Price/Book 2.97xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of STRIDES PHARMA SCIENCE

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of STRIDES PHARMA SCIENCE is calculated as :

Current Market Cap [ ₹6,309.2 Cr] as on Dec 20,2024

(/) Book Value [ ₹2,122.5 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 2.97x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for STRIDES PHARMA SCIENCE , the investors are currently willing to pay '2.97 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of STRIDES PHARMA SCIENCE !

The chart below summarizes the trend in P/B Ratio of STRIDES PHARMA SCIENCE over the last five years.

Historical PB (Price/Book ) ratio chart of STRIDES PHARMA SCIENCE


PB Ratio Performance Analysis for STRIDES PHARMA SCIENCE

- STRIDES PHARMA SCIENCE 's latest p/b ratio is 2.97x.

- STRIDES PHARMA SCIENCE 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.95x.

- STRIDES PHARMA SCIENCE 's operated at median p/b ratio of 1.32x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, STRIDES PHARMA SCIENCE 's p/b ratio peaked in Mar2024 at 3.39x.

- STRIDES PHARMA SCIENCE 's p/b ratio hit its five-year low in Mar2020 of 1.15x.


How does STRIDES PHARMA SCIENCE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
STRIDES PHARMA SCIENCE 2,122.472.976,309.2
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.82433,920.0
CIPLA LTD26,619.904.47118,917.0
DR REDDYS LABORATORIES LTD28,123.503.98112,017.0
ZYDUS LIFESCIENCES LTD19,829.504.9497,997.1
DIVIS LABORATORIES LTD13,571.0011.43155,160.0
MANKIND PHARMA LTD9,339.8412.38115,661.0
TORRENT PHARMACEUTICALS LTD6,856.1516.95116,231.0
LUPIN LTD14,175.806.9197,978.6
AUROBINDO PHARMA LTD29,842.802.4172,060.1
ABBOTT INDIA LTD3,658.7316.6360,853.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs STRIDES PHARMA SCIENCE 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.41x
Max industry PB 16.95x
Median industry PB 6.82x
Average industry PB 8.17x



You may also like the below Video Courses